Relationship of CD8+ T cell noncytotoxic anti-HIV response to CD4+ T cell number in untreated asymptomatic HIV-infected individuals

被引:28
作者
Castelli, JC
Deeks, SG
Shiboski, S
Levy, JA [1 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA
关键词
D O I
10.1182/blood-2001-11-0078
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
During chronic HIV infection, asymptomatic individuals demonstrate a strong CD8(+) cell noncytotoxic antiviral response (CNAR). With the onset of symptoms or reduction in CD4(+) cell counts, CNAR decreases. Presently, it is recommended that infected individuals receive antiretroviral therapy if CD4(+) cell counts fall below 350 cells/muL. To determine whether CNAR lends support to this recommendation for initiation of antiretroviral treatment, we examined CNAR in 20 healthy, untreated, HIV-infected men exhibiting a range of CD4(+) cell numbers. Our results indicate that the asymptomatic untreated HIV-infected individuals with less than 300 CD4(+) cells/muL had a significantly lower CNAR than those with higher CD4(+) cell counts. These data on CNAR in untreated, healthy, HIV-infected individuals support the current recommendation for when to initiate antiretroviral therapy. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:4225 / 4227
页数:3
相关论文
共 14 条
[1]   Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome [J].
Barker, E ;
Mackewicz, CE ;
Reyes-Terán, G ;
Sato, A ;
Stranford, SA ;
Fujimura, SH ;
Christopherson, C ;
Chang, SY ;
Levy, JA .
BLOOD, 1998, 92 (09) :3105-3114
[2]   CLINICAL-EVALUATION OF BRANCHED DNA SIGNAL AMPLIFICATION FOR QUANTIFYING HIV TYPE-1 IN HUMAN PLASMA [J].
CAO, YZ ;
HO, DD ;
TODD, J ;
KOKKA, R ;
URDEA, M ;
LIFSON, JD ;
PIATAK, M ;
CHEN, S ;
HAHN, BH ;
SAAG, MS ;
SHAW, GM .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (03) :353-361
[3]   Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel [J].
Carpenter, CCJ ;
Cooper, DA ;
Fischl, MA ;
Gatell, JM ;
Gazzard, BG ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schechter, M ;
Schooley, RT ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03) :381-390
[4]   HIV-1 EXPRESSION IN CHIMPANZEES CAN BE ACTIVATED BY CD8+ CELL DEPLETION OR CMV INFECTION [J].
CASTRO, BA ;
HOMSY, J ;
LENNETTE, E ;
MURTHY, KK ;
EICHBERG, JW ;
LEVY, JA .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 65 (03) :227-233
[5]  
GOMEZ AM, 1994, CLIN EXP IMMUNOL, V97, P68
[6]   CHARACTERIZATION OF THE AIDS-ASSOCIATED RETROVIRUS REVERSE-TRANSCRIPTASE AND OPTIMAL CONDITIONS FOR ITS DETECTION IN VIRIONS [J].
HOFFMAN, AD ;
BANAPOUR, B ;
LEVY, JA .
VIROLOGY, 1985, 147 (02) :326-335
[7]   AN ACTIVATED CD8+ T-CELL PHENOTYPE CORRELATES WITH ANTI-HIV ACTIVITY AND ASYMPTOMATIC CLINICAL STATUS [J].
LANDAY, AL ;
MACKEWICZ, CE ;
LEVY, JA .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 69 (01) :106-116
[8]   Controlling HIV pathogenesis: The role of the noncytotoxic anti-HIV response of CD8(+) T cells [J].
Levy, JA ;
Mackewicz, CE ;
Barker, E .
IMMUNOLOGY TODAY, 1996, 17 (05) :217-224
[9]   RECOVERY OF AIDS-ASSOCIATED RETROVIRUSES FROM PATIENTS WITH AIDS OR AIDS-RELATED CONDITIONS AND FROM CLINICALLY HEALTHY-INDIVIDUALS [J].
LEVY, JA ;
SHIMABUKURO, J .
JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (04) :734-738
[10]  
MACKEWICZ CE, 1994, LANCET, V344, P1671, DOI 10.1016/S0140-6736(94)90459-6